CRNX — CRINETICS PHARMACEUTICALS INToday's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.
- Congress trades
- 6
- all time
- Members · 12m
- 1
- 1 buys · 1 sells · by trade date
- Latest filing
- 09-04
- 2026-09-04
- Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
- 0
- every row filed inside 45 days
- 13F holders
- 207
- all listed · 2026-03-31
Congress: statutory ranges, filed up to 45 days after the trade · 13F: quarter-end snapshots, filed up to 45 days lateras of 2026-10-29
Congress · disclosure timeline
By trade date · 24 months · 5 rows ▲ buy, ▼ sell; height = lower bound (log scale). Trade date, not filing date — the filing lag is in the table below.5 dated disclosures in the window, placed by trade date; magnitudes are the disclosed lower bounds, against gridlines at $15K, $250K, $5M.
Members active in CRNX
12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).| Member | Rows | Net disclosed flow for this ticker: purchases minus sales, computed as a net range on the disclosed amounts. A lower bound is provable, never a point. | Number of committees the member sat on as of their latest trade date in the window, from the cc0-legislators roster snapshot. Context, never an allegation; jurisdiction overlap needs the sector join. |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. D–CA-31 | 2 | −$49.0K to $0 | 2 |
1 member
| Filed | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2026-09-04 | Gilbert Ray Cisneros, Jr. D–CA-31 | SELL | Traded 07-30 +36d | $15K–$50K | ||
| 2026-04-07 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 03-03 +35d | $1K–$15K | ||
| 2025-05-06 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 04-17 +19d | $1K–$15K | ||
| 2025-04-10 | Josh Gottheimer D–NJ-5 | SELL JT (jointly owned) | Traded 03-19 +22d | $1K–$15K | ||
| 2025-02-11 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 01-29 +13d | $1K–$15K | ||
| 2024-10-03 | Josh Gottheimer D–NJ-5 | BUY JT (jointly owned) | Traded 09-25 +8d | $1K–$15K |
13F holders · Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt. · longs only
| # | Filer | Value | Securities | Flags | derived by Public Filings from this build's reviewed ticker-mapping holders list for this share class; that list carries each holder's share count, share change and filed date, which this table does not show, but no document links — the EDGAR link opens the filer's 13F list·§ |
|---|---|---|---|---|---|
| 1 | FMR LLC | $572M | 1 | derived ·§ EDGAR ↗ | |
| 2 | BlackRock, Inc. | $308M | 1 | derived ·§ EDGAR ↗ | |
| 3 | FARALLON CAPITAL MANAGEMENT, L.L.C. | $303M | 1 | derived ·§ EDGAR ↗ | |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | $296M | 1 | derived ·§ EDGAR ↗ | |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $170M | 1 | derived ·§ EDGAR ↗ | |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | $168M | 1 | derived ·§ EDGAR ↗ | |
| 7 | Janus Henderson Group Ltd. | $164M | 1 | derived ·§ EDGAR ↗ | |
| 8 | EcoR1 Capital, LLC | $156M | 1 | derived ·§ EDGAR ↗ | |
| 9 | Bellevue Group AG | $119M | 1 | derived ·§ EDGAR ↗ | |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | $90.1M | 1 | derived ·§ EDGAR ↗ | |
| 11 | STATE STREET CORP | $87.3M | 1 | derived ·§ EDGAR ↗ | |
| 12 | Pictet Asset Management Holding SA | $68.2M | 1 | derived ·§ EDGAR ↗ | |
| 13 | BNP Paribas Asset Management Holding S.A. | $62.3M | 1 | derived ·§ EDGAR ↗ | |
| 14 | Novo Holdings A/S | $56.3M | 1 | derived ·§ EDGAR ↗ | |
| 15 | RTW INVESTMENTS, LP | $52.7M | 1 | derived ·§ EDGAR ↗ | |
| 16 | ADAR1 Capital Management, LLC | $41.4M | 1 | derived ·§ EDGAR ↗ | |
| 17 | AMERICAN CENTURY COMPANIES INC | $38.2M | 1 | derived ·§ EDGAR ↗ | |
| 18 | SUVRETTA CAPITAL MANAGEMENT, LLC | $37.9M | 1 | derived ·§ EDGAR ↗ | |
| 19 | ORBIMED ADVISORS LLC | $36.3M | 1 | derived ·§ EDGAR ↗ | |
| 20 | MORGAN STANLEY | $33.4M | 1 | derived ·§ EDGAR ↗ | |
| 21 | JENNISON ASSOCIATES LLC | $32.9M | 1 | derived ·§ EDGAR ↗ | |
| 22 | DIMENSIONAL FUND ADVISORS LP | $30.9M | 1 | derived ·§ EDGAR ↗ | |
| 23 | NORTHERN TRUST CORP | $30.6M | 1 | derived ·§ EDGAR ↗ | |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30.3M | 1 | derived ·§ EDGAR ↗ | |
| 25 | Candriam S.C.A. | $30.2M | 1 | derived ·§ EDGAR ↗ |
Show all 207 holders
| # | Filer | Value | Securities | Flags | Src·§ |
|---|
All 165 13F filers reporting this share class are listed. Method ↗
Crowding — not available in this build. No holder rows for the selected period, so no percentile can be ranked.
Congress ↔ notable managers · CRNX
Congress · last 90 days
- Buyers
- 0 — —
- Sellers
- 1 Gilbert Ray Cisneros, Jr. D–CA-31 $15K–$50K
filed 2026-07-31 → 2026-10-29 · statutory ranges
Notable managers · quarter ended 2026-03-31
- Adding
- 0 — $0 held
- Trimming
- 0 — $0 held
by shares · $ = value heldNEW + ADD vs TRIM + EXIT, by share count. $ = reported value now, not the change. · CRINETICS PHARMACEUTICALS IN
| Date | Who | Change | Size |
|---|---|---|---|
| 2026-09-04 | Gilbert Ray Cisneros, Jr. Congress | SELL | $15K–$50K |
1 newest, by filing date · 13F rows are quarter-end snapshots, not trades
Congress vs filers
12 monthsCongress net (rows)1 buy / 1 sell
Congress net ($ bound)−$49.0K to $0
Filersnot computedThe filer side needs per-issuer quarter-over-quarter actions, which the published aggregate does not carry for this issuer. Convergence and divergence are stated only when both sides are computed.